Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Vasc Surg. 2015 Jun 6;64(3):766–778.e5. doi: 10.1016/j.jvs.2015.04.399

Figure 2.

Figure 2

Circulating monocyte phenotypes following lower extremity endovascular revascularization. A, Classic monocytes, identified by expression of CD14 only (CD14+/CD16−), remained stable over time. Pro-inflammatory monocytes, identified by co-expression of CD14 and CD16, also remained stable over time, although the presence of this subtype appeared to demonstrate a downward trend following revascularization. B–C, Integrin surface expression (CD18, CD11a, and CD11b) was similar between the two monocyte phenotypes. CD14+/CD16− cells demonstrated a greater percentage of HLA DR+ cells across all time points compared to CD14+/CD16+ cells (p=.021).